Lee, M., Abraham, T., Claggett, B., maron, M., Miao, Z., Meder, B., Olivotto, I., Heitner, S., Jacoby, D., Malik, F., Kupfer, S., Wohltman, A., Coats, C. (2025). Abstract 4370461: Aficamten is safe and effective in oHCM with comorbidities obesity, hypertension, and diabetes: a SEQUOIA-HCM sub-study. Circulation. https://doi.org/10.1161/circ.152.suppl_3.4370461